ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

Activists To Seek $660 Million For Breast Cancer Research, Legislation To Declare An “Epidemic”

February 12, 1993

Construction Not Dead After All; DCPC Board Okays Architect/ Engineering Support Contract

February 13, 1987